During the past decade, Medical Center Kalimat conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Center Kalimat" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medical Center Kalimat" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Cancer" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Dyslipidemia" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Medical Center Kalimat" in a lesser frequency.

Most popular intervention types in "Medical Center Kalimat" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Evolocumab" (1 trials), "K-877" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center Kalimat" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Center Kalimat". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Medical Center Kalimat, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center Kalimat, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".